WHO ICTRP trial
Comparison of the effects of atorvastatin and rosuvastatin in patients with type…
IRCT20250320065133N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20250320065133N1 |
|---|---|
| Public title | Comparison of the effects of atorvastatin and rosuvastatin in patients with type 2 diabetes |
| Scientific title | Comparison of the effects of atorvastatin and rosuvastatin on the levels of furin, blood sugar and lipid indices in patients with type 2 diabetes |
| Primary sponsor | Kerman University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Type 2 diabetes. Diabetes mellitus due to underlying condition |
| Interventions | Intervention 1: First intervention group: Patients with type 2 diabetes mellitus will be treated with atorvastatin to reduce cholesterol and LDL-C and thereby inhibit microvascular and macrovascular complications. Patients will take this… |
| Registration date | Apr 27, 2025 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: